Scholarly article on 1-naphtho[1,2-d]thiazol-2-yl-3-phenyl-5-p-tolyl-formazan 32829-23-5 from

DOI: 10.1007/BF00480719

Source and publish data:

(1970)

Update date:2022-08-05

Topics:

Authors:

Tyurenkova,G.N.

Bednyagina,N.P.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Nanjing Samwon International Limited

Contact:+86-25-84873444

Address:1108, BLDG B, New Century Plaza, No 1, South Taiping Rd.,
Jitat Company Ltd

Contact:852-27701081

Address:Room 2509, New Tech Plaza, 34 Tai Yau St., San Po Kong, HK
Changzhou BaoKang Pharmaceutical & Chemical Co., Ltd

Contact:(86) 519-88782201 88784080 88785278

Address:Henglin town, changzhou,Jiangsu
Shanghai Yuanding Chem. Sci. & Tech. Co., Ltd.

website:http://www.shydtec.com

Contact:86-21-57721279

Address:Science and Technology Park, Songjiang District, Shanghai, China
Hubei Onward Bio-Development Co., Ltd.

Contact:+86-718-8417012

Address:No.517,Shizhou Avenue,Enshi City,Hubei Province,China,445002

Synthesis and antimicrobial activity of some 2-[p-substituted-phenyl]benzoxazol-5-yl-arylcarboxyamides

Doi:10.1002/1521-4184(200208)335:6<283::AID-ARDP283>3.0.CO;2-M
(2002)
Synthesis and optical properties of novel anthracene-based stilbene derivatives containing an 1,3,4-oxadiazole unit

Doi:10.1016/j.dyepig.2011.10.004
(2012)
Synthesis and reactivity of monoborylacetylene derivatives

Doi:10.1002/1099-0682(200102)2001:2<373::AID-EJIC373>3.0.CO;2-6
(2001)
Discovery of (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2-(dimethylamino)ethanone (CHMFL-FLT3-122) as a Potent and Orally Available FLT3 Kinase Inhibitor for FLT3-ITD Positive Acute Myeloid Leukemia

Doi:10.1021/acs.jmedchem.5b01611
(2015)
Total synthesis of a protected form of 2,6-anhydro-5-azido-3,5-dideoxy-2-C-hydroxymethyl-L-allo-heptose; a potential precursor of analogs of C-glycosides of neuraminic acid

Doi:10.1016/S0957-4166(00)00460-2
(2000)
Synthesis of a fluorescent arabinofuranosyl disaccharide: A probe for arabinosyltransferase activity in Mycobacterium tuberculosis

Doi:10.1016/S0040-4039(00)02161-4
(2001)